The UPV/EHU and the pharmaceutical company Praxis will use nanotechnology in their fight against Chagas disease

The NanoBioCel research group of the Universidad del País Vasco (UPV/EHU) and the Basque pharmaceutical company Praxis participate in the European Berenice project, funded with 4.5 million Euros. Its objective is to improve, by means of nanotechnology, the only drug that exists to combat Chagas disease, an illness which affects 13 million people per year, above all in the third world.

Views: 18

Tags: nanoBasque´s


You need to be a member of The International NanoScience Community to add comments!

Join The International NanoScience Community

Welcome - about us

Welcome! Nanopaprika was cooked up by Hungarian chemistry PhD student in 2007. The main idea was to create something more personal than the other nano networks already on the Internet. Community is open to everyone from post-doctorial researchers and professors to students everywhere.

There is only one important assumption: you have to be interested in nano!

Nanopaprika is always looking for new partners, if you have any idea, contact me at

Dr. András Paszternák, founder of Nanopaprika

Next partner events of TINC

We are Media Partner of:

© 2015   Created by András Paszternák, PhD (founder).   Powered by

Badges  |  Report an Issue  |  Terms of Service